Skip to content

Study to assess the effect of nirgundi taila in patients with pilonidal sinus.

Randomized open control clinical study to evaluate the efficacy of nirgundi taila in the management of nadivrana w.s.r. pilonidal sinus. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110153
Enrollment
80
Registered
2026-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L059- Pilonidal cyst and sinus without abscess

Interventions

None listed

Sponsors

Dr Rishikumar Ramesh Thakur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Pain and discharge from the sinus tract 2 Pilonidal sinus disease of the intergluteal region 3 Sinus tract up to 3 cm

Exclusion criteria

Exclusion criteria: 1)Recurrent sacrococcygeal piloniodal sinus disease(nadi-vrana) 2)Acute pilonidal sinus disease and highly complicated sinus 3)History of pilonidal surgery 4)Associated with Malignancy 5)Patients who are suffering with or have history of systemic disease like DM, TB, etc 6)K/c/o DM/HIV/HBsAG

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of nirgundi taila in nadivrana with special reference to pilonidal sinusTimepoint: 15 days

Secondary

MeasureTime frame
1)To evaluate the effect of nirgundi taila on associated symptoms of nadivrana pain,discharge,swelling 2)To measure the reduction in sinus tract length using a probe 3) To determine the recurrence rate of nadivrana after the intervention 4) To evaluate the tolerability of nirgundi taila in comparison with silver nitrate in 15 daysTimepoint: 15 days

Countries

India

Contacts

Public ContactDrRishikumar Ramesh Thakur

Yashwant ayurvedic college post graduate training and research centre kodoli

dr.abhijit7777@gmail.com9011747576

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026